Document:

Exhibit 4.2

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED 

 

As of December 31, 2021, Blue Water Vaccines Inc.’s
(the “Company,” “we,” “us” and “our”) securities were not registered under Section 12
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Pursuant
to our Amended and Restated Certificate of Incorporation, our authorized capital stock consists of 250,000,000 shares of common stock,
and 10,000,000 shares of preferred stock, $0.00001 par value. The following description summarizes the material terms of our capital stock
and does not purport to be complete. It is subject to, and qualified in its entirety by reference to, our Amended and Restated
Certificate of Incorporation and our Amended and Restated Bylaws, each of which is incorporated by reference as an exhibit to our Annual
Report on Form 10-K for the year ended December 31, 2021 (the “Report”) of which this Exhibit 4.2 is a part.

 

Defined terms used herein but not otherwise defined
shall have the meaning ascribed to such terms in the Report.

 

Common Stock 

 

Our common stock is listed on the Nasdaq Capital Market under the symbol
“BWV.”

 

Under the terms of our Amended and Restated Certificate of Incorporation,
holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders, including
the election of directors, and do not have cumulative voting rights. The holders of outstanding shares of common stock are entitled to
receive dividends out of assets or funds legally available for the payment of dividends of such times and in such amounts as our board
of directors from time to time may determine. Our common stock is not entitled to pre-emptive rights and is not subject to conversion
or redemption. Upon liquidation, dissolution or winding up of our company, the assets legally available for distribution to stockholders
are distributable ratably among the holders of our common stock after payment of liquidation preferences, if any, on any outstanding payment
of other claims of creditors. The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected
by the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future.

 

Preferred Stock 

 

Under the terms of our Amended and Restated
Certificate of Incorporation, our board of directors will be authorized, without further action by
the stockholders, to establish one or more class or series, and fix the relative rights and preferences of the company’s undesignated
capital stock. 

 

Anti-Takeover Effects of Delaware Law and Our Amended and Restated
Certificate of Incorporation and Amended and Restated Bylaws

 

Some provisions of Delaware law, our Amended and Restated Certificate
of Incorporation and our Amended and Restated Bylaws could prohibit or delay mergers or other takeover or change in control attempts and,
accordingly, may discourage attempts to acquire us even though such a transaction may offer our stockholders the opportunity to sell their
stock at a price above the prevailing market price.

 

These provisions, summarized below, are intended to discourage coercive
takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of
us to first negotiate with our board of directors. We believe that the benefits of the increased protection of our potential ability to
negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging
these proposals because negotiation of these proposals could result in an improvement of their terms.

 

     

     

    

 

Delaware Anti-Takeover Statute 

 

We are subject to Section 203 of the General Corporation Law of the
State of Delaware, which prohibits persons deemed to be “interested stockholders” from engaging in a “business combination”
with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business
combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another
prescribed exception applies. Generally, an “interested stockholder” is a person who, together with affiliates and associates,
owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation’s
voting stock. Generally, a “business combination” includes a merger, asset or stock sale, or other transaction resulting in
a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions
not approved in advance by the board of directors.

 

Choice of Forum 

 

Our Amended and Restated Certificate of Incorporation provides that,
unless we consent in writing to an alternative forum, to the fullest extent permitted by law, that derivative actions brought in our name,
actions against directors, officers and employees for breach of fiduciary duty and certain other actions may be brought only in the Court
of Chancery in the State of Delaware, except any action (A) as to which the Court of Chancery in the State of Delaware determines that
there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent
to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive
jurisdiction of a court or forum other than the Court of Chancery or (C) for which the Court of Chancery does not have subject matter
jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service
of process on such stockholder’s counsel. Although we believe this provision benefits us by providing increased consistency in the
application of law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the
extent it is enforceable, the provision may have the effect of discouraging lawsuits against our directors and officers.

 

Our Amended and Restated Certificate of Incorporation provides that
the exclusive forum provision will be applicable to the fullest extent permitted by applicable law, subject to certain exceptions. Section
27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange
Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any
duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. In addition,
our Amended and Restated Certificate of Incorporation provides that, unless we consent in writing to the selection of an alternative forum,
the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the exclusive forum for
the resolution of any complaint asserting a cause of action arising under the Securities Act or the rules and regulations promulgated
thereunder. We note, however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive
compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent
jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the
rules and regulations thereunder.

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our common
stock is Continental Stock Transfer & Trust Company. The Transfer Agent’s address is 1 State Street, 30th Floor,
New York, New York 10004.

 

Listing

 

Our common stock is traded
on The Nasdaq Capital Market under the trading symbol “BWV.”Exhibit 4.5

 

DESCRIPTION OF SECURITIES REGISTERED PURSUANT
TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

 

The following summary of the material terms of
the securities of Kimbell Tiger Acquisition Corporation is not intended to be a complete summary of the rights and preferences of such
securities and is subject to and qualified by reference to our bylaws and amended and restated certificate of incorporation incorporated
by reference as exhibits to the our Annual Report on Form 10-K for the year ended December 31, 2021 (the “Report”)
and applicable Delaware law. We urge you to read our bylaws and amended and restated certificate of incorporation in their entirety for
a complete description of the rights and preferences of our securities.

 

Certain Terms

 

Unless otherwise stated in this exhibit, or the
context otherwise requires, references to:

 

		•	“Board” are to our Board of Directors;

 

		•	“common stock” are to our Class A common stock, par value $0.0001 per share, and our
non-economic Class B common stock, par value $0.0001 per share, collectively;

 

		•	“DGCL” are to the General Corporation Law of the State of Delaware;

 

		•	“equity-linked securities” are to any securities of our company or any of our subsidiaries
which are convertible into, or exchangeable or exercisable for, equity securities of our company or such subsidiary, including any securities
issued by our company or any of our subsidiaries which are pledged to secure any obligation of any holder to purchase equity securities
of our company or any of our subsidiaries, and including Opco Units;

 

		•	“Exchange Act” are to the Securities Exchange Act of 1934, as amended;

 

		•	“final prospectus” are to the prospectus of the company filed with the SEC pursuant to Rule 424(b)(4) under
the Securities Act on February 4, 2022 in connection with our IPO;

 

		•	“founder shares” are to Class B Units of Opco initially issued to our sponsor in a private
placement prior to the IPO (or the Class A Units of Opco into which such Class B Units of Opco will convert) and a corresponding
number of shares of our non-economic Class B common stock;

 

		•	“initial stockholders” are to holders of our founder shares and sponsor shares;

 

		•	“management” or our “management team” are to our officers and directors;

 

		•	“Opco” are to our operating subsidiary, Kimbell Tiger Operating Company, LLC;

 

		•	“Opco LLC Agreement” are to the limited liability company agreement of Opco;

 

		•	“Opco Units” are to the Class A Units and Class B Units of Opco, collectively;

 

		•	“private placement warrants” are to the warrants to purchase shares of our Class A common
stock issued to our sponsor in a private placement simultaneously with the closing of the IPO and warrants that may be issued upon conversion
of working capital loans (as described herein);

 

		•	“IPO” are to our initial public offering, which was consummated on February 8, 2022;

 

		•	“public shares” are to shares of our Class A common stock sold as part of the units in
the IPO (whether they were purchased in the IPO or subsequently in the open market) and, unless otherwise stated herein, the 2,500 shares
of our Class A common stock forming part of the sponsor shares;

 

		•	“public stockholders” are to the holders of our public shares, including our sponsor, officers
and directors to the extent our sponsor, officers or directors purchase public shares, provided that each of their status as a “public
stockholder” shall only exist with respect to such public shares;

 

     

     

    

 

		•	“public warrants” are to our warrants sold as part of the units in the IPO (whether they are
purchased in the IPO or subsequently in the open market);

 

		•	“SEC” are to the U.S. Securities and Exchange Commission;

 

		•	“Securities Act” are to the Securities Act of 1933, as amended;

 

		•	“sponsor” are to Kimbell Tiger Acquisition Sponsor, LLC, a Delaware limited liability company
and a subsidiary of KRP Opco;

 

		•	“sponsor shares” are to the 100 Class A Units of Opco and corresponding number of shares
of our non-economic Class B common stock (which together will be exchangeable into shares of Class A common stock after our
initial business combination on a one-for-one basis) and the 2,500 shares of our Class A common stock purchased by our sponsor in
a private placement prior to the IPO;

 

		•	“units” are to our units, each of which consists of one share of our Class A common stock
and one-half of one redeemable warrant;

 

		•	“warrant agreement” are to that certain Warrant Agreement, dated February 3, 2022, between
the company and Continental Stock Transfer & Trust Company, as warrant agent; and

 

		•	“we,” “us,” “our,” “company,” “our company,”
or “TGR” are to Kimbell Tiger Acquisition Corporation, a Delaware corporation, or, where applicable, members of its management
team.

 

General

 

Pursuant to our amended and restated certificate
of incorporation, our authorized capital stock consists of 225,000,000 shares of Class A common stock, $0.0001 par value, 25,000,000
shares of our Class B common stock, $0.0001 par value, and 1,000,000 shares of undesignated preferred stock, $0.0001 par value. The
following description summarizes certain terms of our capital stock as set out more particularly in our amended and restated certificate
of incorporation. Because it is only a summary, it may not contain all the information that is important to you.

 

Units

 

Each unit consists of one whole share of our Class A
common stock and one-half of one warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common
stock at a price of $11.50 per share, subject to adjustment as described in the warrant agreement. Pursuant to the warrant agreement,
a warrantholder may exercise its warrants only for a whole number of shares of our Class A common stock. This means that only a whole
warrant may be exercised at any given time by a warrantholder.

 

The Class A common stock and warrants comprising
the units began separate trading on March 28, 2022. Following such separation, holders have the option to continue to hold units
or separate their units into the component securities.

 

Common Stock

 

Upon the closing of our IPO, there were 28,752,500
shares of our common stock outstanding, consisting of:

 

		•	23,000,000 shares of our Class A common stock underlying the units issued in the IPO;

 

		•	2,500 shares of our Class A common stock held by our sponsor; and

 

		•	5,750,100 shares of Class B common stock held by our sponsor.

 

Common stockholders of record are entitled to
one vote for each share held on all matters to be voted on by stockholders. Holders of our Class A common stock and holders of our
Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required
by law. Unless specified in our amended and restated certificate of incorporation or bylaws, or as required by applicable provisions of
the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required
to approve any such matter voted on by our stockholders. There is no cumulative voting with respect to the election of directors, with
the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. The holders
of our Class A common stock are entitled to receive ratable dividends when, as and if declared by the Board out of funds legally
available therefor. Holders of our Class B common stock do not have any right to receive a distribution upon a liquidation, dissolution
or winding up of TGR.

 

     

     

    

 

Because our amended and restated certificate of
incorporation authorizes the issuance of up to 225,000,000 shares of our Class A common stock, if we were to enter into a business
combination, we may (depending on the terms of such a business combination) be required to increase the number of shares of our Class A
common stock which we are authorized to issue at the same time as our stockholders vote on the business combination to the extent we seek
stockholder approval in connection with our business combination.

 

Our Board is divided into three classes with only
one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting
of stockholders) serving a three-year term. In accordance with the NYSE corporate governance requirements, we are not required to hold
an annual meeting until no later than one year after our first fiscal year end following our listing on the NYSE. Under Section 211(b) of
the DGCL, we are, however, required to hold an annual meeting of stockholders for the purposes of electing directors in accordance with
our bylaws, unless such election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders
to elect new directors prior to the consummation of our initial business combination, and thus, we may not be in compliance with Section 211(b) of
the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting prior to the consummation
of our initial business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery
in accordance with Section 211(c) of the DGCL.

 

We will provide our public stockholders with the
opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation
of our initial business combination including interest earned on the funds held in the trust account and not previously released to pay
taxes of the company or Opco, divided by the number of then outstanding public shares and Class A Units of Opco (other than those
held by TGR), subject to the limitations described herein. The amount in the trust account is initially anticipated to be approximately
$10.30 per public share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by
the deferred underwriting commissions we will pay to the underwriter. Pursuant to the Opco LLC Agreement and a letter agreement that our
sponsor, officers and directors have entered into with us, they have agreed that any founder shares and sponsor shares will not be entitled
to redemption rights, and they will waive any such redemption rights for any public shares held by them, in connection with the completion
of our business combination. Unlike many blank check companies that hold stockholder votes and conduct proxy solicitations in conjunction
with their initial business combinations and provide for related redemptions of public shares for cash upon completion of such initial
business combinations even when a vote is not required by law, if a stockholder vote is not required by law and we do not decide to hold
a stockholder vote for business or other legal reasons, we will, pursuant to our amended and restated certificate of incorporation, conduct
the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing our
initial business combination. Our amended and restated certificate of incorporation requires these tender offer documents to contain substantially
the same financial and other information about the initial business combination and the redemption rights as is required under the SEC’s
proxy rules. If, however, stockholder approval of the transaction is required by law, or we decide to obtain stockholder approval for
business or other legal reasons, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation
pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek stockholder approval, we will complete our initial
business combination only if a majority of the outstanding shares of common stock voted are voted in favor of the business combination.
A quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the company
representing a majority of the voting power of all outstanding shares of capital stock of the company entitled to vote at such meeting.
However, the participation of our sponsor, officers, directors, advisors or their affiliates in privately-negotiated transactions (as
described in the final prospectus), if any, could result in the approval of our business combination even if a majority of our public
stockholders vote, or indicate their intention to vote, against such business combination. For purposes of seeking approval of the majority
of our outstanding shares of common stock voted, non-votes will have no effect on the approval of our business combination once a quorum
is obtained. We intend to give approximately 30 days (but not less than 10 days nor more than 60 days) prior written notice of any such
meeting, if required, at which a vote will be taken to approve our business combination. These quorum and voting thresholds, and the voting
agreements of our initial stockholders, may make it more likely that we will consummate our initial business combination.

 

If we seek stockholder approval of our initial
business combination and we do not conduct redemptions or repurchases in connection with our business combination pursuant to the tender
offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as
defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate
of 20% of our Class A common stock, which we refer to as the “Excess Shares.” However, we would not be restricting our
stockholders’ ability to vote all of their shares (including Excess Shares) for or against our business combination. Our stockholders’
inability to redeem the Excess Shares will reduce their influence over our ability to complete our business combination, and such stockholders
could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such stockholders will
not receive redemption distributions with respect to the Excess Shares if we complete the business combination. And, as a result, such
stockholders will continue to hold that number of shares exceeding 20% and, in order to dispose of such shares would be required to sell
their stock in open market transactions, potentially at a loss.

 

     

     

    

 

If we seek stockholder approval in connection
with our business combination, our initial stockholders have agreed to vote their founder shares and any public shares purchased during
or after our IPO in favor of our initial business combination. As a result, in addition to our initial stockholders’ founder shares
and sponsor shares, we would need 8,625,001, or 37.5% (assuming all outstanding shares are voted and the over-allotment option is not
exercised), or 1,437,501, or 6.25% (assuming only the minimum number of shares representing a quorum are voted and the over-allotment
option is not exercised), of the 23,000,000 public shares sold in the IPO to be voted in favor of the business combination (assuming all
outstanding shares are voted) in order to have our initial business combination approved. Additionally, each public stockholder may elect
to redeem its public shares irrespective of whether it votes for or against the proposed transaction (subject to the limitation described
in the preceding paragraph).

 

Pursuant to our amended and restated certificate
of incorporation, if we do not complete our business combination within 15 months from the closing of the IPO (or up to 21 months, if
the sponsor exercises its extension options), we will (i) cease all operations except for the purpose of winding up, (ii) as
promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less an amount required to satisfy taxes
of the company and Opco and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public
shares and Class A Units of Opco (other than those held by TGR), which redemption will completely extinguish public stockholders’
rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as
promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our Board, dissolve
and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other
applicable law. Pursuant to the Opco LLC Agreement and a letter agreement that our sponsor, officers and directors have entered into with
us, they have agreed that any founder shares held by them are subject to forfeiture, and will not be entitled to liquidating distributions
from the trust account, and they will waive any such rights to liquidating distributions for any founder shares, if we fail to complete
our business combination within 15 months from the closing of the IPO (or up to 21 months, if the sponsor exercises its extension options).
However, if our sponsor, officers or directors acquire public shares, other than sponsor shares, in or after the IPO, they will be entitled
to liquidating distributions from the trust account with respect to such public shares and the sponsor shares if we fail to complete our
business combination within the prescribed time period.

 

In the event of a liquidation, dissolution or
winding up of the company after a business combination, our stockholders are entitled to share ratably in all assets remaining available
for distribution to them after payment of liabilities and after provision is made for each class of stock, if any, having preference over
the common stock. Our stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to
the common stock, except that we will provide our public stockholders with the opportunity to redeem their public shares for cash equal
to their pro rata share of the aggregate amount then on deposit in the trust account, upon the completion of our initial business combination,
subject to the limitations described herein.

 

Founder Shares

 

The founder shares include shares of our Class B
common stock and Class B Units of Opco (or the Class A Units of Opco into which such Class B Units will convert in connection
with our initial business combination). The Class B Units of Opco will convert into Class A Units of Opco in connection with
our initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations
and the like. The founder shares are exchangeable for shares of our Class A common stock after the time of our initial business combination,
subject to adjustment for stock splits, dividends, reorganizations and the like.

 

     

     

    

 

Together, the founder shares are substantially
similar to the shares of Class A common stock included in the units sold in the IPO, except that:

 

		•	the founder shares consist of Class B Units of Opco (and any Class A Units of Opco into which
such Class B Units are converted) and a corresponding number of shares of our Class B common stock, which together will be exchangeable
for shares of our Class A common stock after the time of our initial business combination on a one-for-one basis, subject to adjustment
pursuant to certain anti-dilution rights; following our initial business combination, holders of our Class A common stock and holders
of our Class B common stock will generally vote together as a single class on matters presented for a stockholder vote, except as
required by Delaware law or stock exchange rule, with each share of our common stock entitling the holder to one vote;

 

		•	the founder shares are subject to certain transfer restrictions, as described in more detail below;

 

		•	pursuant to the Opco LLC Agreement and a letter agreement that our sponsor, officers and directors
have entered into with us, they have agreed:

 

		o	that any founder shares and sponsor shares held by them will not be entitled to redemption rights,
and they will waive any such redemption rights for any public shares held by them, in connection with the completion of our initial business
combination;

 

		o	that any founder shares and sponsor shares held by them will not be entitled to redemption rights,
and they will waive any such redemption rights for any public shares held by them, in connection with a stockholder vote to amend our
amended and restated certificate of incorporation in a manner that would affect the substance or timing of our obligation to redeem 100%
of our public shares if we have not consummated an initial business combination within 15 months from the closing of the IPO (or up to
21 months, if the sponsor exercises its extension options);

 

		o	that any founder shares held by them are subject to forfeiture, and thus will not be entitled to liquidating distributions from the
trust account, and they will waive any such rights to liquidating distributions for any founder shares, if we fail to complete our initial
business combination within 15 months from the closing of the IPO (or up to 21 months, if the sponsor exercises its extension options)
(although they will be entitled to liquidating distributions from the trust account with respect to any
public shares and sponsor shares they hold if we fail to complete our business combination within the prescribed time frame);

 

		o	in certain limited circumstances the Class B Units of Opco will have more limited rights to current or liquidating distributions
from us. If we submit our initial business combination to our public stockholders for a vote, we will complete our initial business combination
only if a majority of the outstanding shares of common stock voted are voted in favor of the initial business combination. Our initial
stockholders have agreed to vote any founder shares and sponsor shares held by them and any public shares purchased during or after the
IPO in favor of our initial business combination. As a result, in addition to our initial stockholders’ founder shares and sponsor
shares, we would need 8,625,001, or 37.5% (assuming all outstanding shares are voted and the over-allotment option is not exercised),
or 1,437,501, or 6.25% (assuming only the minimum number of shares representing a quorum are voted and the over-allotment option is not
exercised), of the 23,000,000 public shares sold in the IPO to be voted in favor of an initial business combination in order to have such
initial business combination approved; and

 

		•	the Class A common stock into which the founder shares are exchangeable
are entitled to registration rights.

 

In the case that additional shares of our Class A
common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the IPO and related to the closing
of an initial business combination, the number of Class A Units of Opco into which the Class B Units of Opco will convert may
be adjusted (unless the holders of a majority of the outstanding founder shares agree to waive such adjustment with respect to any such
issuance or deemed issuance) so that, after all founder shares have been exchanged for shares of our Class A common stock, the aggregate
number of shares of our Class A common stock received by holders in exchange for founder shares would equal 20% of the sum of the
total outstanding shares of our Class A common stock upon completion of the IPO (excluding the sponsor shares and any shares issuable
upon exercise of any warrants) plus all shares of our Class A common stock and equity-linked securities issued or deemed issued in
connection with the business combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the
business combination). In addition, the number of outstanding shares of our Class B common stock will be adjusted through a stock
split or stock dividend so that the total number of outstanding shares of our Class B common stock corresponds to the total number
of Class A Units of Opco outstanding (other than those held by TGR) plus the total number of Class A Units of Opco into which
the Class B Units of Opco are entitled to convert.

 

     

     

    

 

Sponsor Shares

 

In May 2021, our sponsor purchased 100 Class A
Units of Opco and a corresponding number of shares of our Class B common stock (which together will be exchangeable into shares of
Class A common stock after our initial business combination on a one-for-one basis) and 2,500 shares of our Class A common stock.

 

Our initial stockholders have agreed not to transfer,
assign or sell any founder shares or sponsor shares held by them, and any shares of our Class A common stock acquired upon exchange
of founder shares, until one year after the date of the consummation of our initial business combination or earlier if, subsequent to
our business combination, (i) the last sale price of our common stock equals or exceeds $12.00 per share (as adjusted for stock splits,
stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing at least 150
days after our initial business combination or (ii) we consummate a subsequent liquidation, merger, stock exchange or other similar
transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or
other property. The holders of the founder shares and sponsor shares have also agreed (A) to vote any shares owned by them in favor
of any proposed business combination and (B) not to convert any shares in connection with a stockholder vote to approve a proposed
initial business combination.

 

Preferred Stock

 

Our amended and restated certificate of incorporation
provides that shares of preferred stock may be issued from time to time in one or more series. Our Board is authorized to fix the voting
rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications,
limitations and restrictions thereof, applicable to the shares of each series. Our Board may, without stockholder approval, issue preferred
stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and
could have anti-takeover effects. The ability of our Board to issue preferred stock without stockholder approval could have the effect
of delaying, deferring or preventing a change of control of us or the removal of existing management. No shares of preferred stock were
issued or registered in the IPO, and we have no preferred stock outstanding. Although we do not currently intend to issue any shares of
preferred stock, we cannot assure you that we will not do so in the future.

 

Warrants

 

Public Stockholders’ Warrants

 

Each whole warrant entitles the registered holder
to purchase one whole share of our Class A common stock at a price of  $11.50 per share, subject to adjustment as discussed
below, at any time commencing 30 days after the completion of our initial business combination, provided that we have an effective registration
statement under the Securities Act covering the shares of our Class A common stock issuable upon exercise of the warrants and a current
prospectus relating to them is available (or we permit holders to exercise their warrants on a cashless basis under the circumstances
specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue
sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrantholder may exercise its warrants only for
a whole number of shares of our Class A common stock. This means that only a whole warrant may be exercised at any given time by
a warrantholder. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m., New York
City time, or earlier upon redemption or liquidation. Upon the exercise of a warrant to purchase one share of our Class A common
stock, we will exercise a corresponding warrant to acquire one Class A Unit of Opco.

 

We will not be obligated to deliver any shares
of our Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless
a registration statement under the Securities Act with respect to the shares of our Class A common stock underlying the warrants
is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect
to registration. No warrant will be exercisable and we will not be obligated to issue shares of our Class A common stock upon exercise
of a warrant unless the Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt
under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the
two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise
such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant.
In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant
will have paid the full purchase price for the unit solely for the share of our Class A common stock underlying such unit.

 

     

     

    

 

While we have registered the shares of Class A
common stock issuable upon exercise of the warrants in the registration statement on Form S-1 that we filed in connection with our
IPO (the “IPO Registration Statement”) because the warrants will become exercisable 30 days after the completion of our initial
business combination, which may be within one year of the consummation of our IPO, we do not plan to keep a prospectus covering such shares
current until required to pursuant to the warrant agreement governing the warrants. However, because the warrants will be exercisable
until their expiration date of up to five years after the completion of our initial business combination, in order to comply with the
requirements of Section 10(a)(3) of the Securities Act following the consummation of our initial business combination, we have
agreed that, as soon as practicable, but in no event later than 20 business days, after the closing of our initial business combination,
we will use our commercially reasonable efforts to file with the SEC a post-effective amendment to the IPO Registration Statement or a
new registration statement covering the registration under the Securities Act of the Class A common stock issuable upon exercise
of the warrants and thereafter will use our commercially reasonable efforts to cause the same to become effective within 60 business days
following our initial business combination and to maintain a current prospectus relating to the Class A common stock issuable upon
exercise of the warrants until the expiration of the warrants in accordance with the provisions of the warrant agreement.

 

Notwithstanding the above, if our Class A
common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition
of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of
warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities
Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but we will use our
commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common
stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying
the warrants, multiplied by the excess of the “fair market value” (as defined below) over the
exercise price of the warrants by (y) the fair market value. The “fair market value” as used in this paragraph shall
mean the volume weighted average price of our shares of Class A common stock as reported during the 10 trading days ending on the
third trading day prior to the date on which the notice of exercise is received by the warrant agent.

 

Redemption of warrants when our Class A
common stock equals or exceeds $18.00.

 

Once the warrants become exercisable, we may call
the warrants for redemption for cash:

 

		•	in whole and not in part;

 

		•	at a price of  $0.01 per warrant;

 

		•	upon not less than 30 days’ prior written notice of redemption (the
 “30-day redemption period”) to each warrantholder; and

 

		•	if, and only if, the reported last sale price of our Class A common
stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like)
for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption to the warrantholders.

 

We will not redeem
the warrants for cash unless a registration statement under the Securities Act covering the shares of Class A common stock issuable
upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available
throughout the 30-day redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising
warrantholder to pay the exercise price for each warrant being exercised. If and when the warrants become redeemable by us, we may exercise
our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities
laws.

 

We have established the last of the redemption
criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise
price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrantholder will be entitled
to exercise its warrant prior to the scheduled redemption date. However, the price of our Class A common stock may fall below the
$18.00 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well
as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

 

     

     

    

 

Redemption Procedures.

 

A holder of a warrant may notify us in writing
in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent
that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual
knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the shares of our Class A common
stock outstanding immediately after giving effect to such exercise.

 

Anti-Dilution Adjustments.

 

If the number of outstanding shares of our Class A
common stock is increased by a stock dividend payable in shares of our Class A common stock, or by a split-up of shares of our Class A
common stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares
of our Class A common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding
shares of our Class A common stock. A rights offering to holders of our Class A common stock entitling holders to purchase shares
of our Class A common stock at a price less than the fair market value will be deemed a stock dividend of a number of shares of our
Class A common stock equal to the product of  (i) the number of shares of our Class A common stock actually sold
in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable
for our Class A common stock) multiplied by (ii) one minus the quotient of  (x) the price per share of our Class A
common stock paid in such rights offering divided by (y) the fair market value. For these purposes (i) if the rights offering
is for securities convertible into or exercisable for our Class A common stock, in determining the price payable for our Class A
common stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon
exercise or conversion and (ii) fair market value means the volume weighted average price of our Class A common stock as reported
during the ten trading day period ending on the trading day prior to the first date on which the shares of our Class A common stock
trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

In addition, if we, at any time while the warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to all or substantially all the
holders of our Class A common stock on account of such shares of our Class A common stock (or other shares of our capital stock
into which the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends, (c) to
satisfy the redemption rights of the holders of our Class A common stock in connection with a proposed initial business combination,
(d) to satisfy the redemption rights of the holders of our Class A common stock in connection with a stockholder vote to approve
an amendment to our amended and restated certificate of incorporation that would affect the substance or timing of our obligation to redeem
100% of our Class A common stock if we have not consummated our initial business combination within 15 months from the closing of
the IPO (or up to 21 months, if the sponsor exercises its extension options), or (e) in connection with the redemption of our public
shares upon our failure to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately
after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each
share of our Class A common stock in respect of such event.

 

If the number of outstanding shares of our Class A
common stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of our Class A common
stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or
similar event, the number of shares of our Class A common stock issuable on exercise of each warrant will be decreased in proportion
to such decrease in outstanding shares of our Class A common stock.

 

Whenever the number of shares of our Class A
common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted
by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the
number of shares of our Class A common stock purchasable upon the exercise of the warrants immediately prior to such adjustment,
and (y) the denominator of which will be the number of shares of our Class A common stock so purchasable immediately thereafter.

 

     

     

    

 

In case of any reclassification or reorganization
of the outstanding shares of our Class A common stock (other than those described above or that solely affects the par value of such
shares of our Class A common stock), or in the case of any merger or consolidation of us with or into another corporation (other
than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization
of our outstanding shares of our Class A common stock), or in the case of any sale or conveyance to another corporation or entity
of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders
of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in
the warrants and in lieu of the shares of our Class A common stock immediately theretofore purchasable and receivable upon the exercise
of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the
holder of the warrants would have received if such holder had exercised his, her or its warrants immediately prior to such event. If less
than 70% of the consideration receivable by the holders of our Class A common stock in such a transaction is payable in the form
of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter
market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly
exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as
specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose
of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during
the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of
the warrants. The warrant exercise price will not be adjusted for other events.

 

The warrants have been issued in registered form
under the warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement
provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective
provision or mistake (including to conform the terms of the warrants to those described in the final prospectus, but requires the approval
by the holders of at least 50% of the then outstanding warrants to make any change that adversely affects the interests of the registered
holders of warrants. Investors should review a copy of the warrant agreement, which is filed as an exhibit to the company’s Annual
Report on Form 10-K for the year ended December 31, 2022, for a complete description of the terms and conditions applicable
to the warrants.

 

In addition, if we issue additional shares of
common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination
at a newly issued price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined
in good faith by our Board and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder
shares held by the sponsor or such affiliates, as applicable, prior to such issuance), the exercise price of the warrants will be adjusted
(to the nearest cent) to be equal to 115% of the newly issued price and the $18.00 per share redemption trigger price described above
under “—Redemption of warrants when our Class A common stock equals or exceeds $18.00” will be adjusted (to the
nearest cent) to be equal to 180% of the newly issued price.

 

The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrantholders
do not have the rights or privileges of holders of our Class A common stock or any voting rights until they exercise their warrants
and receive shares of our Class A common stock.

 

After the issuance of shares of our Class A
common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be
voted on by stockholders.

 

No fractional shares of Class A common stock
will be issued upon exercise of the warrants on a cashless basis. If, upon exercise of the warrants on a cashless basis, a holder would
be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of shares of Class A
common stock to be issued to the holder.

 

     

     

    

 

Private Placement Warrants

 

The private placement warrants (including the
shares of our Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable
or salable until 30 days after the completion of our initial business combination (except, among other limited exceptions as described
below under “Transfers of Founder Shares and Private Placement Warrants,” to our officers and directors and other persons
or entities affiliated with our sponsor). Except as described below, the private placement warrants have terms and provisions that are
identical to those of the warrants sold as part of the units in the IPO, including as to exercise price, exercisability and exercise period.
Upon the exercise of a warrant to purchase one share of our Class A common stock, TGR will exercise a corresponding warrant to acquire
one Class A Unit of Opco.

 

In order to finance transaction costs in connection
with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may,
but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned
amounts out of the proceeds of the trust account released to us. In the event that our initial business combination does not close, we
may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account
would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant
at the option of the lender. Such warrants would be identical to the private placement warrants, including as to exercise price, exercisability
and exercise period.

 

Our sponsor has agreed not to transfer, assign
or sell any of the private placement warrants (including the our Class A common stock issuable upon exercise of any of these warrants)
until the date that is 30 days after the date we complete our initial business combination, except that, among other limited exceptions
as described below under “Transfers of Founder Shares and Private Placement Warrants” made to our officers and directors and
other persons or entities affiliated with our sponsor.

 

Transfers of Founder Shares and Private Placement
Warrants

 

The founder shares, private placement warrants
and any shares of our Class A common stock issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant
to a letter agreement entered into by our sponsor, directors, officers and us. This letter agreement provides that the founder shares,
and any shares of our Class A common stock acquired upon exchange of founder shares, may not be transferred, assigned or sold until
the earlier of  (x) one year after the completion of our initial business combination or earlier if, subsequent to our business
combination, the last sale price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock
dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least
150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, capital stock exchange,
reorganization or other similar transaction after our initial business combination that results in all of our stockholders having the
right to exchange their shares of common stock for cash, securities or other property.

 

The shares of our Class B common stock comprising
a portion of the founder shares and sponsor shares cannot be transferred without transferring a corresponding number of Opco Units and
vice versa.

 

The letter agreement provides that the private
placement warrants may not be transferred, assigned or sold until 30 days following the completion of our initial business combination.

 

Additionally, in the event of (i) our
liquidation prior to the completion of our initial business combination or (ii) the completion of a liquidation, merger, stock exchange
or other similar transaction which results in all of our stock holders having the right to exchange their shares of common stock for cash,
securities or other property subsequent to our completion of our initial business combination, the lock-up period shall terminate. However,
in the case of clauses (a) through (f) below, such securities may be transferred during the lock-up period to certain permitted
transferees, provided that they enter into a written agreement agreeing to be bound by these transfer restrictions. Permitted transfers
include: (a) transfers to our officers or directors, any affiliates or family members of any of our officers or directors, any members
of our sponsor or their affiliates, or any affiliates of our sponsor or any employees of any affiliates of our sponsor; (b) in the
case of an individual, transfers by gift to members of the individual’s immediate family or to a trust, the beneficiary of which
is a member of one of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in
the case of an individual, transfers by virtue of laws of descent and distribution upon death of the individual; (d) in the case
of an individual, transfers pursuant to a qualified domestic relations order; (e) transfers by virtue of the laws of the state of
Delaware or our sponsor’s operating agreement upon dissolution of our sponsor; and (f) transfers by private sales or transfers
made in connection with the consummation of a business combination at prices no greater than the price at which the securities were originally
purchased.

 

Permitted transferees would be subject to the
same written agreements as our sponsor, directors and officers with respect to (i) voting any founder shares held by them in favor
of the initial business combination, (ii) agreeing to not propose any amendment to our amended and restated certificate of incorporation
that would affect the substance or timing of our obligation to redeem 100% of public shares if we do not complete an initial business
combination within 15 months from the closing of the IPO (or up to 21 months, if the sponsor exercises its extension options) and (iii) waiving
their redemption rights and rights to certain distributions.

 

     

     

    

 

Dividends

 

We have not paid any cash dividends on our common
stock to date and do not intend to pay cash dividends prior to the completion of an initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial conditions
subsequent to completion of an initial business combination. The payment of any cash dividends subsequent to an initial business combination
will be within the discretion of our Board at such time. Our Board is not currently contemplating and does not anticipate declaring any
stock dividends in the foreseeable future. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive
covenants we may agree to in connection therewith.

 

Our Transfer Agent and Warrant Agent

 

The transfer agent for our common stock and warrant
agent for our warrants is Continental Stock Transfer & Trust Company. We have agreed to indemnify Continental Stock Transfer &
Trust Company in its roles as transfer agent and warrant agent, its agents and each of its stockholders, directors, officers and employees
against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any liability
due to any gross negligence, willful misconduct or bad faith of the indemnified person or entity.

 

Continental Stock Transfer & Trust Company
has agreed that it has no right of set-off or any right, title, interest or claim of any kind to, or to any monies in, the trust account,
and has irrevocably waived any right, title, interest or claim of any kind to, or to any monies in, the trust account that it may have
now or in the future. Accordingly, any indemnification provided will only be able to be satisfied, or a claim will only be able to be
pursued, solely against us and our assets outside the trust account and not against any monies in the trust account or interest earned
thereon.

 

Our Amended and Restated Certificate of Incorporation

 

Our amended and restated certificate of incorporation
contains certain requirements and restrictions relating to our IPO that will apply to us until the completion of our initial business
combination. These provisions cannot be amended without the approval of the holders of 65% of our common stock. Our initial stockholders,
who beneficially owned shares representing 20% of the total outstanding shares of our Class A common stock upon the closing of the
IPO (assuming the exchange of all the founder shares for Class A common stock and that they do not purchase any units in the IPO
and excluding the sponsor shares), will participate in any vote to amend our amended and restated certificate of incorporation and will
have the discretion to vote in any manner they choose. Specifically, our amended and restated certificate of incorporation provides, among
other things, that:

 

		•	if we do not complete our initial business combination within 15 months from the closing of the IPO (or
up to 21 months, if the sponsor exercises its extension options), we will (i) cease all operations except for the purpose of winding
up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor,
redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account
including interest earned on the funds held in the trust account and not previously released to pay taxes of the company or Opco (less
an amount required to satisfy taxes of the company and Opco up to $100,000 of interest to pay dissolution expenses), divided by the number
of then outstanding public shares and Class A Units of Opco (other than those held by TGR), which redemption will completely extinguish
public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject
to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining
stockholders and our Board, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of
creditors and the requirements of other applicable law;

 

		•	prior to our initial business combination, we may not issue additional
shares of capital stock that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on any
initial business combination;

 

		•	although we do not intend to enter into a business combination with a target
business that is affiliated with our sponsor, KRP or either of their officers or directors, including TGR or one or more of our sponsor’s
or KRP’s portfolio companies, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee
of independent directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or another independent
entity that commonly renders valuation opinions stating that the consideration to be paid by us in such a business combination is fair
to our company from a financial point of view;

 

     

     

    

 

		•	if a stockholder vote on our initial business combination is not required
by law and we do not decide to hold a stockholder vote for business or other legal reasons, we will offer to redeem our public shares
pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing
our initial business combination, which documents would contain substantially the same financial and other information about our initial
business combination and the redemption rights as is required under Regulation 14A of the Exchange Act;

 

		•	the NYSE rules require that our initial business combination must
occur with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in trust (net
of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting commissions held
in trust) at the time the agreement to enter into the initial business combination is made;

 

		•	if our stockholders approve an amendment to our amended and restated certificate of incorporation that
would affect the substance or timing of our obligation to redeem 100% of our public shares if we have not consummated an initial business
combination within 15 months from the closing of the IPO (or up to 21 months, if the sponsor exercises its extension options), we will
provide our public stockholders with the opportunity to redeem all or a portion of their shares of our Class A common stock upon
such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account and not previously released to pay taxes of the company or Opco, divided by the number of
then outstanding public shares and Class A Units of Opco (other than those held by TGR); and

 

		•	we will not effectuate our initial business combination solely with another
blank check company or a similar company with nominal operations.

 

In addition, our
amended and restated certificate of incorporation provides that under no circumstances will we redeem our public shares in an amount that
would cause our net tangible assets to be less than $5,000,001.

 

Certain Anti-Takeover Provisions of Delaware
Law and our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws

 

We have opted out of Section 203 of the DGCL.
However, our amended and restated certificate of incorporation contains similar provisions providing that we may not engage in certain
 “business combinations” with any “interested stockholder” for a three-year period following the time that the
stockholder became an interested stockholder, unless:

 

		•	prior to such time, our Board approved either the business combination or the transaction which resulted
in the stockholder becoming an interested stockholder;

 

		•	upon consummation of the transaction that resulted in the stockholder becoming
an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced,
excluding certain shares; or

 

		•	at or subsequent to that time, the business combination is approved by
our Board and by the affirmative vote of holders of at least 66 2/3% of the outstanding voting stock that is not owned by the interested
stockholder.

 

Generally, a “business
combination” includes a merger, asset or stock sale or certain other transactions resulting in a financial benefit to the interested
stockholder. Subject to certain exceptions, an “interested stockholder” is a person who, together with that person’s
affiliates and associates, owns, or within the previous three years owned, 20% or more of our voting stock.

 

Under certain circumstances, this provision will
make it more difficult for a person who would be an “interested stockholder” to effect various business combinations with
a corporation for a three-year period. This provision may encourage companies interested in acquiring our company to negotiate in advance
with our Board because the stockholder approval requirement would be avoided if our Board approves either the business combination or
the transaction which results in the stockholder becoming an interested stockholder. These provisions also may have the effect of preventing
changes in our Board and may make it more difficult to accomplish transactions which stockholders may otherwise deem to be in their best
interests.

 

Our amended and restated certificate of incorporation
provides that our sponsor and its respective affiliates, any of their respective direct or indirect transferees of at least 20% of our
outstanding common stock and any group as to which such persons are party to, do not constitute “interested stockholders”
for purposes of this provision.

 

     

     

    

 

Our amended and restated certificate of incorporation
provides that our Board be classified into three classes of directors. As a result, in most circumstances, a person can gain control of
our Board only by successfully engaging in a proxy contest at two or more annual meetings.

 

Our authorized but unissued common stock and preferred
stock are available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including
future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved
common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest,
tender offer, merger or otherwise.

 

Exclusive Forum for Certain Lawsuits

 

Our amended and restated certificate of incorporation
requires, unless we consent in writing to the selection of an alternative forum, that (i) any derivative action or proceeding brought
on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee to
us or our stockholders, (iii) any action asserting a claim against us, our directors, officers or employees arising pursuant to any
provision of the DGCL or our amended and restated certificate of incorporation or bylaws, or (iv) any action asserting a claim against
us, our directors, officers or employees governed by the internal affairs doctrine may be brought only in the Court of Chancery in the
State of Delaware, except any claim (A) as to which the Court of Chancery of the State of Delaware determines that there is an indispensable
party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction
of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court
or forum other than the Court of Chancery or (C) for which the Court of Chancery does not have subject matter jurisdiction. If an
action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such
stockholder’s counsel. Although we believe this provision benefits us by providing increased consistency in the application of Delaware
law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is
enforceable, the provision may have the effect of discouraging lawsuits against our directors and officers, although our stockholders
will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder.

 

Notwithstanding the foregoing, our amended and
restated certificate of incorporation provides that the exclusive forum provision will not apply to suits brought to enforce a duty or
liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Section 27 of
the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange
Act or the rules and regulations thereunder. Additionally, unless we consent in writing to the selection of an alternative forum,
our amended and restated certificate of incorporation provides that the federal courts will be the exclusive forum for the resolution
of any complaint asserting a cause of action arising under the Securities Act against us or any of our directors, officers, other employees
or agents. Section 22 of the Securities Act, however, created concurrent jurisdiction for federal and state courts over all suits
brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Accordingly, there
is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other
companies’ charter documents has been challenged in legal proceedings. While the Delaware courts have determined that such exclusive
forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the
exclusive forum provisions, and there can be no assurance that such provisions will be enforced by a court in those other jurisdictions.
Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of and consented
to these provisions; however, we note that investors cannot waive compliance with the federal securities laws and the rules and regulations
thereunder.

 

Special Meeting of Stockholders

 

Our bylaws provide that special meetings of our
stockholders may be called only by a majority vote of our Board, by our Chief Executive Officer or by our Chairman.

 

Advance Notice Requirements for Stockholder
Proposals and Director Nominations

 

Our bylaws provide that stockholders seeking to
bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual meeting of
stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s notice will need to be received
by the company secretary at our principal executive offices not later than the close of business on the 90th day nor earlier than the
close of business on the 120th day prior to the anniversary date of the immediately preceding annual meeting of stockholders. Pursuant
to Rule 14a-8 under the Exchange Act, proposals seeking inclusion in our annual proxy statement must comply with the notice periods
contained therein. Our bylaws also specify certain requirements as to the form and content of a stockholders’ meeting. These provisions
may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors
at our annual meeting of stockholders. Our bylaws allow the chairman of the meeting at a meeting of the stockholders to adopt rules and
regulations for the conduct of meetings which may have the effect of precluding the conduct of certain business at a meeting if the rules and
regulations are not followed. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation
of proxies to elect the acquirer’s own slate of directors or otherwise attempting to influence or obtain control of us.

 

     

     

    

 

Action by Written Consent

 

Any action required or permitted to be taken by
our common stockholders must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written
consent of the stockholders other than with respect to our Class B common stock.

 

Classified Board of Directors

 

Our Board is divided into three classes, Class I,
Class II and Class III, with members of each class serving staggered three-year terms. Our amended and restated certificate
of incorporation provides that the authorized number of directors may be changed only by resolution of the Board. Subject to the terms
of any preferred stock, any or all of the directors may be removed from office at any time, but only for cause and only by the affirmative
vote of holders of a majority of the voting power of all then outstanding shares of our capital stock entitled to vote generally in the
election of directors, voting together as a single class. Any vacancy on our Board, including a vacancy resulting from an enlargement
of our Board, may be filled only by vote of a majority of our directors then in office.

 

Class B Common Stock Consent Right

 

For so long as any shares of our Class B
common stock remain outstanding, we may not, without the prior vote or written consent of the holders of a majority of the shares of our
Class B common stock then outstanding, voting separately as a single class, amend, alter or repeal any provision of our certificate
of incorporation, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal of would alter or change the
powers, preferences or relative, participating, optional or other or special rights of the Class B common stock. Any action required
or permitted to be taken at any meeting of the holders of our Class B common stock may be taken without a meeting, without prior
notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of the
outstanding Class B common stock having not less than the minimum number of votes that would be necessary to authorize or take such
action at a meeting at which all shares of our Class B common stock were present and voted.

 

Securities Eligible for Future Sale

 

We have 28,752,600 shares of common stock outstanding.
Of these shares, the 23,000,000 sold in our IPO are freely tradable without restriction or further registration under the Securities Act,
except for any shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the remaining
5,752,600 shares and all 14,100,000 private placement warrants are restricted securities under Rule 144, in that they were issued
in private transactions not involving a public offering, and the shares of our Class A common stock and Class B common stock
and private placement warrants are subject to transfer restrictions as described herein. These restricted securities are subject to registration
rights as more fully described below under “—Registration Rights.”

 

Rule 144

 

Pursuant to Rule 144, a person who has beneficially
owned restricted shares of our common stock or warrants for at least six months would be entitled to sell their securities provided that
(i) such person is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding,
a sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at least three months before the sale and
have filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as
we were required to file reports) preceding the sale.

 

     

     

    

 

Persons who have beneficially owned restricted
shares of our common stock or warrants for at least six months but who are our affiliates at the time of, or at any time during the three
months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month
period only a number of securities that does not exceed the greater of:

 

		•	1% of the total number of shares of common stock then outstanding, which equals 287,500 shares; or

 

		•	the average weekly reported trading volume of the common stock during the
four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.

 

Sales by our affiliates
under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information
about us.

 

Restrictions on the Use of Rule 144 by
Shell Companies or Former Shell Companies

 

Rule 144 is not available for the resale
of securities initially issued by shell companies (other than business combination related shell companies) or issuers that have been
at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following
conditions are met:

 

		•	the issuer of the securities that was formerly a shell company has ceased to be a shell company;

 

		•	the issuer of the securities is subject to the reporting requirements of
Section 13 or 15(d) of the Exchange Act;

 

		•	the issuer of the securities has filed all Exchange Act reports and materials
required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such
reports and materials), other than Current Reports on Form 8-K; and

 

		•	at least one year has elapsed from the time that the issuer filed current
Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.

 

As a result, our initial stockholders will be
able to sell their founder shares and private placement warrants, as applicable, pursuant to Rule 144 without registration one year
after we have completed our initial business combination.

 

Registration Rights

 

The holders of the founder shares, private placement
warrants and warrants that may be issued upon conversion of working capital loans (and any shares of our Class A common stock issuable
upon the exercise of the private placement warrants or exchange of the founder shares issued upon exercise of the private placement warrants
and warrants that may be issued upon conversion of working capital loans and upon exchange of the founder shares) are entitled to registration
rights pursuant to the registration rights agreement, dated February 3, 2022, among the company, the sponsor, and certain other security
holders named therein, requiring us to register such securities for resale (in the case of the founder shares, only after they become
exchangeable for shares of our Class A common stock). The holders of these securities, having at least $25 million in the aggregate,
are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have
certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our
initial business combination and rights to require us to register for resale such securities pursuant to Rule 415under the Securities
Act. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

Listing of Securities

 

Our units, Class A common stock and warrants
are listed on the NYSE under the symbols “TGR.U,” “TGR” and “TGR.WS,” respectively. The units will
not be traded after completion of our initial business combination.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]